Riley JL - Search Results

1

CAR T cells for infection, autoimmunity and allotransplantation.

Maldini CR, Ellis GI, Riley JL. Maldini CR, et al. Among authors: riley jl. Nat Rev Immunol. 2018 Oct;18(10):605-616. doi: 10.1038/s41577-018-0042-2. Nat Rev Immunol. 2018. PMID: 30046149 Free PMC article. Review.

2

Ex vivo expansion of polyclonal and antigen-specific cytotoxic T lymphocytes by artificial APCs expressing ligands for the T-cell receptor, CD28 and 4-1BB.

Maus MV, Thomas AK, Leonard DG, Allman D, Addya K, Schlienger K, Riley JL, June CH. Maus MV, et al. Among authors: riley jl. Nat Biotechnol. 2002 Feb;20(2):143-8. doi: 10.1038/nbt0202-143. Nat Biotechnol. 2002. PMID: 11821859

3

Engineering lymphocyte subsets: tools, trials and tribulations.

June CH, Blazar BR, Riley JL. June CH, et al. Among authors: riley jl. Nat Rev Immunol. 2009 Oct;9(10):704-16. doi: 10.1038/nri2635. Nat Rev Immunol. 2009. PMID: 19859065 Free PMC article. Review.

4

Engineering T Cells to Functionally Cure HIV-1 Infection.

Leibman RS, Riley JL. Leibman RS, et al. Among authors: riley jl. Mol Ther. 2015 Jul;23(7):1149-1159. doi: 10.1038/mt.2015.70. Epub 2015 Apr 21. Mol Ther. 2015. PMID: 25896251 Free PMC article. Review.

5

Supraphysiologic control over HIV-1 replication mediated by CD8 T cells expressing a re-engineered CD4-based chimeric antigen receptor.

Leibman RS, Richardson MW, Ellebrecht CT, Maldini CR, Glover JA, Secreto AJ, Kulikovskaya I, Lacey SF, Akkina SR, Yi Y, Shaheen F, Wang J, Dufendach KA, Holmes MC, Collman RG, Payne AS, Riley JL. Leibman RS, et al. Among authors: riley jl. PLoS Pathog. 2017 Oct 12;13(10):e1006613. doi: 10.1371/journal.ppat.1006613. eCollection 2017 Oct. PLoS Pathog. 2017. PMID: 29023549 Free PMC article.

6

CAR Talk: How Cancer-Specific CAR T Cells Can Instruct How to Build CAR T Cells to Cure HIV.

Kim GB, Hege K, Riley JL. Kim GB, et al. Among authors: riley jl. Front Immunol. 2019 Sep 27;10:2310. doi: 10.3389/fimmu.2019.02310. eCollection 2019. Front Immunol. 2019. PMID: 31611880 Free PMC article. Review.

7

HIV-Resistant and HIV-Specific CAR-Modified CD4⁺ T Cells Mitigate HIV Disease Progression and Confer CD4⁺ T Cell Help In Vivo.

Maldini CR, Gayout K, Leibman RS, Dopkin DL, Mills JP, Shan X, Glover JA, Riley JL. Maldini CR, et al. Among authors: riley jl. Mol Ther. 2020 Jul 8;28(7):1585-1599. doi: 10.1016/j.ymthe.2020.05.012. Epub 2020 May 15. Mol Ther. 2020. PMID: 32454027 Free PMC article.

8

Robust expansion of HIV CAR T cells following antigen boosting in ART-suppressed nonhuman primates.

Rust BJ, Kean LS, Colonna L, Brandenstein KE, Poole NH, Obenza W, Enstrom MR, Maldini CR, Ellis GI, Fennessey CM, Huang ML, Keele BF, Jerome KR, Riley JL, Kiem HP, Peterson CW. Rust BJ, et al. Among authors: riley jl. Blood. 2020 Oct 8;136(15):1722-1734. doi: 10.1182/blood.2020006372. Blood. 2020. PMID: 32614969 Free PMC article.

9

Characterization of CAR T cell expansion and cytotoxic potential during Ex Vivo manufacturing using image-based cytometry.

Maldini CR, Love AC, Tosh KW, Chan LL, Gayout K, Smith T, Riley JL. Maldini CR, et al. Among authors: riley jl. J Immunol Methods. 2020 Sep-Oct;484-485:112830. doi: 10.1016/j.jim.2020.112830. Epub 2020 Aug 1. J Immunol Methods. 2020. PMID: 32745474 Free PMC article.

10

Dual CD4-based CAR T cells with distinct costimulatory domains mitigate HIV pathogenesis in vivo.

Maldini CR, Claiborne DT, Okawa K, Chen T, Dopkin DL, Shan X, Power KA, Trifonova RT, Krupp K, Phelps M, Vrbanac VD, Tanno S, Bateson T, Leslie GJ, Hoxie JA, Boutwell CL, Riley JL, Allen TM. Maldini CR, et al. Among authors: riley jl. Nat Med. 2020 Nov;26(11):1776-1787. doi: 10.1038/s41591-020-1039-5. Epub 2020 Aug 31. Nat Med. 2020. PMID: 32868878 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

373 results

Search Page